Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$2.77 - $5.07 $1,662 - $3,042
-600 Reduced 2.29%
25,600 $0
Q3 2022

Nov 14, 2022

SELL
$4.27 - $6.39 $9,393 - $14,058
-2,200 Reduced 7.75%
26,200 $2,000
Q2 2022

Aug 12, 2022

SELL
$3.28 - $6.21 $20,992 - $39,744
-6,400 Reduced 18.39%
28,400 $5,000
Q1 2022

May 12, 2022

SELL
$5.23 - $7.82 $54,915 - $82,110
-10,500 Reduced 23.18%
34,800 $13,000
Q4 2021

Feb 14, 2022

BUY
$7.29 - $10.97 $137,781 - $207,333
18,900 Added 71.59%
45,300 $17,000
Q3 2021

Nov 10, 2021

SELL
$9.01 - $12.01 $57,664 - $76,864
-6,400 Reduced 19.51%
26,400 $7,000
Q2 2021

Aug 11, 2021

BUY
$10.17 - $12.64 $115,938 - $144,096
11,400 Added 53.27%
32,800 $33,000
Q1 2021

May 14, 2021

SELL
$10.88 - $17.05 $576,640 - $903,650
-53,000 Reduced 71.24%
21,400 $39,000
Q4 2020

Feb 16, 2021

BUY
$9.23 - $18.18 $277,823 - $547,218
30,100 Added 67.95%
74,400 $265,000
Q3 2020

Nov 13, 2020

SELL
$9.38 - $12.48 $16,884 - $22,464
-1,800 Reduced 3.9%
44,300 $42,000
Q2 2020

Aug 10, 2020

BUY
$6.21 - $11.83 $286,281 - $545,363
46,100 New
46,100 $52,000
Q1 2020

May 08, 2020

SELL
$5.05 - $8.85 $328,755 - $576,135
-65,100 Closed
0 $0
Q4 2019

Feb 11, 2020

SELL
$8.03 - $11.7 $98,768 - $143,910
-12,300 Reduced 15.89%
65,100 $31,000
Q3 2019

Nov 12, 2019

BUY
$9.05 - $12.22 $228,965 - $309,166
25,300 Added 48.56%
77,400 $45,000
Q2 2019

Aug 14, 2019

SELL
$8.75 - $13.03 $87,500 - $130,300
-10,000 Reduced 16.1%
52,100 $94,000
Q1 2019

May 10, 2019

BUY
$7.72 - $12.81 $479,412 - $795,501
62,100 New
62,100 $58,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $182M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.